Sébastien Martel joined Amicus in May 2021 and currently serves as Chief Business Officer. He brings 25 years of diversified pharmaceutical and biotechnology expertise to Amicus, with extensive experience in rare disease. In his current capacity, Mr. Martel leads the Corporate Strategy, Business Development, Alliance Management, Strategic Planning, and Portfolio Analytics functions. Prior to joining Amicus, Mr. Martel spent 12 years at Sanofi, most recently serving as Senior Vice President and Global Head of Rare Diseases, where he led the global rare disease business through multiple global product launches, commercialization, and disease awareness initiatives, in addition to guiding business development and portfolio strategy. Mr. Martel received a Doctor of Pharmacy Degree (PharmD) from the University of Angers, Faculty of Pharmacy, and an M.B.A. from the INSEAD Business School. He also holds a Masters in Management for the Pharmaceutical Industry from the Burgundy School of Business.